These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21377495)

  • 1. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors.
    Scott MM; Marcus JN; Pettersen A; Birnbaum SG; Mochizuki T; Scammell TE; Nestler EJ; Elmquist JK; Lutter M
    Behav Brain Res; 2011 Sep; 222(2):289-94. PubMed ID: 21377495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.
    LeSage MG; Perry JL; Kotz CM; Shelley D; Corrigall WA
    Psychopharmacology (Berl); 2010 Apr; 209(2):203-12. PubMed ID: 20177882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone.
    Morairty SR; Revel FG; Malherbe P; Moreau JL; Valladao D; Wettstein JG; Kilduff TS; Borroni E
    PLoS One; 2012; 7(7):e39131. PubMed ID: 22768296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking.
    Smith RJ; Aston-Jones G
    Eur J Neurosci; 2012 Mar; 35(5):798-804. PubMed ID: 22356621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naïve or plus-maze-experienced mice.
    Rodgers RJ; Wright FL; Snow NF; Taylor LJ
    Behav Brain Res; 2013 Apr; 243():213-9. PubMed ID: 23333844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of orexin 1 receptors eliminates motor hyperactivity and improves homing response acquisition in juvenile rats exposed to alcohol during early postnatal period.
    Stettner GM; Kubin L; Volgin DV
    Behav Brain Res; 2011 Aug; 221(1):324-8. PubMed ID: 21420437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization.
    Sharf R; Guarnieri DJ; Taylor JR; DiLeone RJ
    Brain Res; 2010 Mar; 1317():24-32. PubMed ID: 20034477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective orexin 1 receptor antagonist SB-334867-A impairs acquisition and consolidation but not retrieval of spatial memory in Morris water maze.
    Akbari E; Naghdi N; Motamedi F
    Peptides; 2007 Mar; 28(3):650-6. PubMed ID: 17161886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy.
    Mishima K; Fujiki N; Yoshida Y; Sakurai T; Honda M; Mignot E; Nishino S
    Sleep; 2008 Aug; 31(8):1119-26. PubMed ID: 18714784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia.
    Johnson PL; Samuels BC; Fitz SD; Lightman SL; Lowry CA; Shekhar A
    Neuropsychopharmacology; 2012 Jul; 37(8):1911-22. PubMed ID: 22453138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers.
    Borgland SL; Chang SJ; Bowers MS; Thompson JL; Vittoz N; Floresco SB; Chou J; Chen BT; Bonci A
    J Neurosci; 2009 Sep; 29(36):11215-25. PubMed ID: 19741128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the orexin/hypocretin system in ethanol conditioned place preference.
    Voorhees CM; Cunningham CL
    Psychopharmacology (Berl); 2011 Apr; 214(4):805-18. PubMed ID: 21107540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement.
    Sharf R; Sarhan M; Brayton CE; Guarnieri DJ; Taylor JR; DiLeone RJ
    Biol Psychiatry; 2010 Apr; 67(8):753-60. PubMed ID: 20189166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress.
    Rusyniak DE; Zaretsky DV; Zaretskaia MV; Durant PJ; DiMicco JA
    Physiol Behav; 2012 Dec; 107(5):743-50. PubMed ID: 22361264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal.
    Plaza-Zabala A; Flores Á; Maldonado R; Berrendero F
    Biol Psychiatry; 2012 Feb; 71(3):214-23. PubMed ID: 21831361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats.
    Richards JK; Simms JA; Steensland P; Taha SA; Borgland SL; Bonci A; Bartlett SE
    Psychopharmacology (Berl); 2008 Jul; 199(1):109-17. PubMed ID: 18470506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice.
    Boyce-Rustay JM; Holmes A
    Neuropsychopharmacology; 2006 Nov; 31(11):2405-14. PubMed ID: 16482087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.
    Riday TT; Fish EW; Robinson JE; Jarrett TM; McGuigan MM; Malanga CJ
    Brain Res; 2012 Jan; 1431():53-61. PubMed ID: 22133306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: Involvement of OX1 and CB1 receptors in the ventral tegmental area.
    Taslimi Z; Haghparast A; Hassanpour-Ezatti M; Safari MS
    Behav Brain Res; 2011 Feb; 217(1):41-6. PubMed ID: 20937330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of orexin-1 receptors in physiologic responses evoked by microinjection of PgE2 or muscimol into the medial preoptic area.
    Rusyniak DE; Zaretsky DV; Zaretskaia MV; DiMicco JA
    Neurosci Lett; 2011 Jul; 498(2):162-6. PubMed ID: 21596094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.